Chronic pain should be considered a disease

February 15, 2008

The concept that chronic pain is a disease in its own right is leading to new specific treatments aimed at physical, psychological, and environmental components of this major disease, including genetic predisposition, according to a world renowned pain medicine expert.

Michael J Cousins AM, MD, DSc, professor and director of the Pain Management Research Institute at the University of Sydney, Royal North Shore Hospital, in Australia, presented the Decade of Pain plenary session on February 14, 2008, at the 24th Annual Meeting of the American Academy of Pain Medicine at the Gaylord Palms in Orlando, Florida.

“Chronic pain is different from acute pain,” explained Dr. Cousins. “If pain persists despite reasonable treatment from a primary care physician and other specialists, the advice of a pain medicine specialist should be sought. The earlier such help is obtained the greater the chance of returning to a reasonable range of life activities.”

According to the National Center for Health Statistics more than one-quarter of Americans (26%) age 20 years and over - or, an estimated 76.5 million Americans - report that they have had a problem with pain. Studies from the Pain Management Research Institute reveal an annual cost of $1.85 billion per 1 million people.

“In the near future, diagnosis and treatment of persistent pain will be markedly different,” Dr. Cousins stated. “Drugs such as morphine that provide only symptomatic relief will be replaced by or supplemented with a new generation of therapies targeted at the disease process.”

The availability of new treatments may challenge the medical system. Dr. Cousins noted that too few pain medicine specialists are being trained and not enough pain patients have access to effective treatments.

“Pain management needs to become a fundamental human right: a bundle of initiatives will be needed in Medicine, Law, Ethics, Politics,” concluded Dr. Cousins.

Dr. Cousins also addressed the genetics of pain and brain imaging research.

Dr. Cousins has been the driving force in Australia, as well as internationally, in drawing attention to evidence that shows that severe persistent pain becomes a “disease entity” and has also championed the concept of pain relief as a basic human right.

Source: American Academy of Pain Medicine

3.3 /5 (4 votes)  

Rank 3.3 /5 (4 votes)
Tags

Relevant PhysicsForums posts

More news stories

Team isolates nerve cells involved in storing long term memory and gene proteins associated with them

(Medical Xpress) -- A research team in Taiwan has succeeded in isolating two nerve cells in fruit fly brains that are believed to be the major players in allowing for the formation of long term memories. Furthermore, ...

Medicine & Health / Neuroscience

created 55 minutes ago | popularity 5 / 5 (3) | comments 0 | with audio podcast report

News of plaque-clearing drug tops week of major advances against Alzheimer's disease

In the last eight days, scientists have delivered a powerful one-two punch in the fight to defeat Alzheimer's disease. At the same time, the White House and members of Congress are proposing increases in Alzheimer's research ...

Medicine & Health / Diseases

created 51 minutes ago | popularity not rated yet | comments 1

To avoid early labor and delivery, weight and diet changes not the answer

One of the strongest known risk factors for spontaneous or unexpected preterm birth – any birth that occurs before the 37th week of pregnancy, most often without a known cause – is already having had one. For women ...

Medicine & Health / Health

created 4 minutes ago | popularity not rated yet | comments 0 | with audio podcast

Joint patent for using the BRCA1 gene as a therapy for cardiovascular disease

St. Michael's Hospital and King Saud University have received their first joint U.S. patent to use the BRCA1 gene as a therapy for cardiovascular disease.

Medicine & Health / Genetics

created 20 minutes ago | popularity not rated yet | comments 0

S.Africa in $208 mln AIDS drug venture with Swiss Lonza

South Africa on Friday unveiled plans for a 1.6 billion rand ($208 million, 157 million euro) pharmaceutical plant, in a joint venture with Swiss biochemicals group Lonza to produce anti-AIDS drugs.

Medicine & Health / HIV & AIDS

created 1 hour ago | popularity not rated yet | comments 0


The power of estrogen -- male snakes attract other males

A new study has shown that boosting the estrogen levels of male garter snakes causes them to secrete the same pheromones that females use to attract suitors, and turned the males into just about the sexiest ...

Could Venus be shifting gear?

(PhysOrg.com) -- ESA’s Venus Express spacecraft has discovered that our cloud-covered neighbour spins a little slower than previously measured. Peering through the dense atmosphere in the infrared, the ...

Experts reveal how plants don't get sunburn

(PhysOrg.com) -- Experts at the University of Glasgow have discovered how plants survive the harmful rays of the sun.

Fool's gold may prove an unlikely alternative to overexploited catalytic materials

Catalytic materials, which lower the energy barriers for chemical reactions, are used in everything from the commercial production of chemicals to catalytic converters in car engines. However, with current catalytic materials ...

SLAC, Stanford team focuses on high-energy electrons to treat cancer

Accelerator physicists at SLAC and cancer specialists from Stanford are working on a new technology that could dramatically reduce the time needed for cancer radiation treatments. The team ran an initial experiment ...

Unpicking HIV’s invisibility cloak

Drug researchers hunting for alternative ways to treat human immunodeficiency virus (HIV) infections may soon have a novel target—its camouflage coat. HIV hides inside a cloak unusually rich in a sugar ...